4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-25-004918
Options or other derivatives
- Chief Financial Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Little Paul Sean · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-10 | Grant or award : show line 1 in the form Stock Option (right to buy) | +175,000 | 175,000 | D |
| 2025-01-10 | Grant or award : show line 2 in the form Restricted Stock Units | +75,000 | 75,000 | D |
Loading xslF345X05/ownership.xml…